Beck Capital Management LLC Takes $3.21 Million Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Beck Capital Management LLC acquired a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 78,947 shares of the real estate investment trust's stock, valued at approximately $3,213,000.

Other hedge funds have also recently made changes to their positions in the company. Assetmark Inc. lifted its holdings in Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock worth $48,492,000 after purchasing an additional 19,542 shares in the last quarter. Daiwa Securities Group Inc. raised its position in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after buying an additional 3,003,845 shares during the last quarter. Caxton Associates LP purchased a new position in shares of Omega Healthcare Investors in the second quarter worth $1,652,000. Van ECK Associates Corp boosted its position in shares of Omega Healthcare Investors by 15.4% during the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust's stock worth $4,167,000 after acquiring an additional 13,367 shares during the last quarter. Finally, Citigroup Inc. grew its stake in Omega Healthcare Investors by 20.1% during the third quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust's stock valued at $14,307,000 after acquiring an additional 58,950 shares in the last quarter. Institutional investors own 65.25% of the company's stock.

Insider Transactions at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Wall Street Analyst Weigh In

OHI has been the subject of several research reports. Wells Fargo & Company reissued an "overweight" rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Berenberg Bank began coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a "buy" rating and a $45.00 price target for the company. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective on the stock in a report on Thursday, October 31st. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Finally, Truist Financial upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research note on Wednesday, September 4th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $40.00.

Omega Healthcare Investors Trading Down 2.0 %

Shares of OHI traded down $0.80 during trading hours on Monday, reaching $39.81. 1,625,361 shares of the company traded hands, compared to its average volume of 1,686,436. The firm has a market cap of $10.75 billion, a price-to-earnings ratio of 29.32, a PEG ratio of 1.26 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The stock's fifty day moving average price is $40.61 and its 200 day moving average price is $37.40. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.73%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio is 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.